Pharma IQ Members

Manufacturing

Gain a solid foundation for your manufacturing process, mitigate risks and ensure compliance. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in domestic and overseas manufacturing to exchange ideas on best practice and share case studies on innovation within the area.

292 results
of 27
Contributor: Dan Jacob
Posted: 11/09/2017
Dan J
After surveying over 1200 life science leaders, this research captures the shared role of quality and manufacturing across enterprise and operational domains in medicine production. Full Content »
Contributor: Elizabeth Mixson
Posted: 15/08/2017
Elizabeth
Our 2017 Banned & Restricted Cosmetic Ingredients Global Index is a one stop shop for access to a global dossier of cosmetic ingredients regulation resources including a global inventory of prohibited substances, restricted ingredients and a overview of recent regulatory changes. Full Content »
Contributor: Pharma IQ
Posted: 11/07/2017
Pharma IQ
Despite some in the market choosing to shut down certain departments, many in the pharma industry are embarking on expansions. Ireland is expected to see a lot of growth Full Content »
Posted: 26/05/2017
DIsposablesa
Representatives from USP, BPOG and BPSA discuss the different standards and guidance protocols that address the use of disposable products and single use systems in biomanufacturing. Namely: Michael Eakins, Ph.D. Vice-Chair, USP Packaging & Distribution Expert Committee; Aidan Sexton, Senior Process Validation Engineer, Janssen Biologic and Patrick Evrard, Sr Manager MSAT - Manufacturing Technologies - Single-Use Systems, GSK Vaccines, Member of BPSA Board of Directors. Full Content »
Contributor: Pharma IQ
Posted: 23/05/2017
Pharma IQ
Ahead of the Cell and Gene Therapy Manufacturing conference, Pharma IQ examines the top 10 challenges that complicate the route to manufacturing commercial cell and gene products. Full Content »
Contributor: Pharma IQ
Posted: 23/05/2017
Pharma IQ
Limitations in compatibility between certain single use system devices for biomanufacturing is a challenge that has raged for quite some time. A number of experts discuss the latest on the matter and the solution that the biotech and biopharma market needs for this sticking point in the industry. Full Content »
Contributor: Pharma IQ
Posted: 16/05/2017
Pharma IQ
Anna Holefors, CEO of In vitro Plant-Tech considers the technologies and trends that could shake up the biomanufacturing space for medicines. Full Content »
Contributor: Pharma IQ
Posted: 02/05/2017
Pharma IQ
Single use systems provide numerous benefits to the process of biomanufacturing including the prospect of faster turnaround times for biotech and biopharma firms. Here Michael Eakins, Vice Chair of the USP Packaging & Distribution Expert Committee and Mike Johnson, Chair of the ASME BPE Polymer Materials Subcommittee discuss some of the standards and guidance that surround the single use systems industry. Full Content »
Contributor: Pharma IQ
Posted: 25/04/2017
Pharma IQ
This heatmap scans the cell and gene manufacturing activity occurring across Europe on the road to commercializing these therapies. Full Content »
Contributor: Pharma IQ
Posted: 07/03/2017
Pharma IQ
Last week, key figures in the biopharma manufacturing industry came together to shape the future of the industry, exchange best practice tips and spot the new opportunities on the horizon for the market. Full Content »
Contributor: Social Monsters.org
Posted: 14/02/2017
default profile icon
After years of resistance, the health care and pharmaceutical industries are now accelerating full steam towards the cloud. In fact, the global health care cloud computing market, valued at $4.5 billion in 2016, will reach $9.5 billion by 2020. Here are the dominant benefits that are drawing these giants to the cloud. Full Content »
292 results
of 27